Effect of omeprazole, lansoprazole, and ranitidine on the dna synthesis of mononuclear cells

Critical Care Medicine

Volumn 27, Issue 1, 1999, Pages 90-94

  Peddicord, Tom E ^a   Olsen, Keith M ^a   Collier, Dean S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Critical care; Lansoprazole; Lymphoblastogenesis; Mononuclear cells; Omeprazole; Ranitidine; Stress ulcer prophylaxis; Surgery; Thymidine; Trauma

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; RANITIDINE;

ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DNA SYNTHESIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INJURY; MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STRESS ULCER; SURGICAL PATIENT; T LYMPHOCYTE;

EID: 0032944871     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199901000-00032     Document Type: Article

References (31)

1. 1. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994; 330:377-381
2. 2. Ben-Menachem T, Fogel R, Patel RV, et al: Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med 1994; 121:568-575
3. 3. Driks MR, Craven DE, Celli BR, et al: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987; 317:1376-1382
4. 4. Tryba M: Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients: Sucralfate versus antacids. Am J Med 1987; 83(Suppl. 3):S117-S124
5. 5. Nielsen HJ, Moesgaard F, Kehlet H: Ranitidine for prevention of post-operative suppression of delayed hypersensitivity. Am J Surg 1989; 157: 291-294
6. 6. Faist E, Mewes A, Strasser T, et al: Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-292
7. 7. Nohr CW, Christou NV, Rode H, et al: In vivo and in vitro humoral immunity in surgical patients. Ann Surg 1984; 200:373-380
8. 8. Richtsmeier WJ, Eisele D: In vivo anergy reversal with cimetidine in patients with cancer. Arch Otolaryngol Head Neck Surg 1986; 112:1074-1077
9. 9. Nielsen HJ, Hammer JH, Moesgaard F, et al: Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity. Surgery 1989; 105:711-717
10. 2 receptors in peripheral blood mononuclear cells. J Biol Chem 1994; 269:9952-9956
11. 2-antagonists in humans. Transplant Proc 1989; 21:1718-1721
12. 12. Adams WJ, Morris DL, Ross WB, et al: Cimetidine preserves non-specific immune function after colonic resection for cancer. Aust N Z J Surg 1994; 64:847-852
13. 13. Foster R, Costanza C, Foster J, et al: Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer 1985; 55:1195-1201
14. 14. Phillips JO, Metzler MH, Palmieri TL, et al: A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med 1996; 24:1793-1800
15. 15. Sitter H, Lorenz W, Klotter HJ, et al: Elevated plasma histamine concentration as a sensitive real-time parameter for distinct phases of the surgical trauma: A tool for technology assessment. Agents Actions 1991; 33: 203-207
16. 16. Dohlsten M, Kallland T, Sjögren HO, et al; Histamine inhibits interleukin-1 production by lipopolysaccharide-stimulated human peripheral blood monocytes. Scand J Immunol 1988; 27: 527-532
17. 2 receptors. J Exp Med 1991; 174:281-284
18. 18. Dohlsten M, Sjögren HO, Carlsson R: Histamine acts directly on human T cells to inhibit interleukin-2 and interferon gamma. Cell Immunol 1987; 108:485-492
19. 19. Carlsson R, Dohlsten M, Sjögren HO: Histamine modulates production of interferon-gamma and interleukin-2 by mitogen-activated human mononuclear blood cells. Cell Immunol 1985; 96: 104-112
20. 20. Beer DJ, Rocklin RE: Histamine modulation of lymphocyte biology: Membrane receptors, signal transduction, and functions. Crit Rev Immunol 1987; 7:55-91
21. 21. Bury TH, Rademecker M: Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 1992; 47:624-629
22. 22. Nair MP, Schwartz SA: Effect of histamine and histamine antagonist on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro. Cell Immunol 1983; 81:50-56
23. 23. Nair MP, Cilik JM, Schwartz SA: Histamine-induced suppressor factor inhibition of NK cells: Reversal with interferon and interleukin 2. J Immunol 1986; 136:2456-2462
24. + T cells by interleukin-2 and cimetidine. Int Arch Allergy Immunol 1992; 97:8-16
25. 25. Park CS, Lee SM, Chung SW, et al: Interleukin-2 and soluble interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma. Chest 1994; 106:400-406
26. 26. McFarland RJ, Bateson MC, Green JRB, et al: Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine. Gastroenterology 1990; 98:278-283
27. 27. Walen A, Bader J-P, Classen M, et al: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989; 320:69-75
28. 28. Lloyd-Davies KA, Rugersson K, Solvell L: Omeprazole in the treatment of Zollinger-Ellison syndrome: A 4-year international study. Aliment Pharmacol Ther 1988; 2:13-32
29. 29. Sontag SJ, Hirschowitz BI, Holt S, et al: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study. Gastroenterology 1992; 102:109-118
30. 30. Spencer CM, Faulds D: Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994; 48:404-430
31. 31. Kountouras J, Boura P, Apostolides G, et al: In vivo effect of omeprazole on HLA-DR expression and the monocyte-macrophage function in patients with duodenal ulcer disease. Immunopharmacol Immunotoxicol 1994; 16: 437-448